arrow
A

Angela Nebbioso

university of campania luigi vanvitelli
H指数:50
被引数:8,309

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Simplification and Derivatization of Quinoline-Containing M41 Lead to the Discovery of NADPH Oxidase Isoform-Selective Inhibitors Effective in Cancer Cells

喹啉基M41的简化与衍生化导致NADPH氧化酶同工酶选择性抑制剂在癌细胞中的发现

2026-01-010
OA
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers

遗传、流行病学、临床和治疗轨迹在结肠癌和直肠癌中的作用

2025-10-270
OAAI
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia

结直肠癌中脂肪组织-肿瘤相互作用:鉴定肿瘤进展和恶病质的(表)遗传学生物标志物

2025-10-060
OAAI
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis

Mettl16介导的MXD4抑制通过激活MYC-MAX轴促进白血病

2025-09-140
OAAI
Disruption of c-Myc/Max heterodimerization induced by a novel anticancer agent endowed with 1,3-diphenylurea moiety: an in silico, chemoproteomics-based, and in vitro combined approach

含有1,3-二苯基脲基团的抗癌药物对c-Myc/Max异二聚体化的破坏:一种计算模拟、化学蛋白质组学为基础和体外相结合的方法

2025-07-210
PRE
“Aging and epigenetic implications in radiotherapy: The promise of BNCT”

“老龄化与放疗中的表观遗传学意义:硼中子俘获疗法(BNCT)的潜力”

2025-05-300
OA
Unveiling New Triazoloquinoxaline-Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9

揭示靶向选择性降解ncBAF染色质重塑亚基BRD9的新型三氮唑喹啉类PROTACs的设计

2025-05-200
PRE
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities (vol 39, pg 1902, 2007)
2024-08-010
PRE
Targeting ROS production through inhibition of NADPH oxidases
2023-10-2612
PRE